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Management Team, BioEnergy’s X Factor
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Stephen J. Gatto, Chairman, CEO
Advisor to President Clinton and Bush
Dr. Lonnie Ingram, Chief Science Officer
University of Florida
Dr. Joseph P. Glas, SVP R&D
VP DuPont Biotechnology
Dr. Mohammed Moniruzzaman, VP R&D
Genencor International
Samuel McConnell, SVP Development
Project finance over $2 B
Rudy Fogleman, VP Operations 




President Bush on BioEnergy’s Chief Science Officer:
“on the leading edge of change”
Our Vision - the BioRefinery
A Day When A Pound Of Sugar Can Replace A Barrel of Crude For Everything 
From The Fuel We Put In Our Cars To The Plastics and Fabrics We Use In Our 
Everyday Lives .
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Sugar 1,4 Butanediol
BioEnergy’s second generation technology – 7 years from today
25°C 35 °C
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Cellulosic $0.03-0.08 $0.10-0.15 $0.60
Biorefinery concept links low cost feedstock approach 
with high value outputs
Source: EIA World Crude Oil Price; USDA Raw Sugar 
Price
The focus is on diversifying plant revenues while building the sustainaible sugar platform. 
Cellulosic technology is not the end game; 
rather it is a means to an end. 
The Market
Biofuels 
Æ 90 billion gallons
Bio-based chemicals and polymers 








by retrofitting or building plants to 
drive down costs and move away 
from food-based raw materials
Diversify revenue by 
introducing novel biocatalysts 
for the manufacture of green 
chemicals and biopolymers
New Paradigm needs a Beginning, Middle and End
The Strategy
8Business Overview
Our strategic business model is supported by proprietary technology; BioEnergy 




• 110Mgpy, Fagan EPC; ICM Design
• 5-year off-take agreement with Getty Oil (provides natural hedge 
against commodity fluctuations)
• $22M in grants and loans from State of Pennsylvania
• Closed $205M debt financing with WestLB, TD Banknorth& Stern Brothers Feb ’08





• 110Mgpy expandable to 220Mgpy
• Key permits in hand
• $20M in grants
• Site lease executed with Port Authority





Led by Dr. Mohammed Moniruzzaman and a world-renowned team of molecular 
biologists, engineers, and chemists, BioEnergy uses its proprietary technology to 
advance the development of its cheap sugar platform.
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Innovative, Integrated Cellulosic Platform































Revolutionary technology - BioEnergy’s “software” will convert 



















BioEnergy’s flexible microbial technology platform 




Adipic acid Lactic acid
Business Overview
Novel Biocatalysts
Through the development of novel biocatalysts for use in state-of-the-art 
biorefineries, BioEnergy has pioneered a progressive, sustainable, and 
economically viable alternative to the traditional petroleum-based production of 
renewable fuels and high-value bio-based intermediates and polymer precursors.
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Commercial D-lactic acid
• BioEnergy broke the D-lactic acid code
• Product already in the market
35 % THF




















Transforming the fuels, chemicals and energy industries with 
biotechnical advantage to push down cost and increase value


































Corinne Young, Director of Government Affairs
BioEnergy International, LLC
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